Epigenetics

  • Andrew D. Hershey
  • Vincenzo Guidetti
  • Noemi Faedda
Chapter
Part of the Headache book series (HEAD)

Abstract

The pathophysiology of migraine is far from resolved. The current theory regards migraine as a complex multifactorial disorder, with both predisposing genetic factors and environmental factors contributing to the attacks [1]. Twin studies have reported that over half of the variation in migraine is attributable to a genetic component, while the remainder is attributable to unshared environmental factors [2–4]. Several studies have identified the role of some genes in the pathophysiology of migraine [5]; however, epigenetic mechanisms may play an important role in the etiology and phenotypic expression of migraine disorders, and these mechanisms may explain how non-genetic factors (such as female hormones, stress, and inflammation) may modulate the severity and frequency of the attacks [1].

Keywords

Epigenetics Headache Pathophysiology Gene Environment Comorbidity 

References

  1. 1.
    Eising E, Datson NA, van den Maagdenberg AMJM, Ferrari MD. Epigenetic mechanisms in migraine: a promising avenue? BMC Med. 2013;11(1):26.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Montagna P. Migraine: a genetic disease? Neurol Sci. 2008;29(Suppl 1):S47–51.CrossRefPubMedGoogle Scholar
  3. 3.
    Russell MB, Ulrich V, Gervil M, Olesen J. Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache. 2002;42(5):332–6.CrossRefPubMedGoogle Scholar
  4. 4.
    Virtanen R, Aromaa M, Koskenvuo M, Sillanpää M, Rose RJ, Metsähonkala L, Helenius H, Anttila P, Kaprio J. Prevalence and incidence of headache in adolescent Finnish twins. Headache. 2009;49(10):1503–12.CrossRefPubMedGoogle Scholar
  5. 5.
    Gormley P, Anttila V, Winsvold BS, Palta P, Esko T, Pers TH, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48(8):856–66. doi: 10.1038/ng.3598.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Waddington CH. The epigenotype. Endeavour. 1942;1:18–20.Google Scholar
  7. 7.
    Waddington CH. The basic ideas of biology. In:Towards a theoretical biology. Edinburgh: Edinburgh University Press; 1968. p. 1–32.Google Scholar
  8. 8.
    Rettner R. Epigenetics: definition and examples. 2013. http://www.livescience.com/37703-epigenetics.html.
  9. 9.
    Kanherkar RR, Bhatia-Dey N, Csoka AB. Epigenetics across the human lifespan. Front Cell Dev Biol. 2014;2:49.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Tollefsbol T. Transgenerational epigenetics: evidence and debate. London: Academic Press; 2014.CrossRefGoogle Scholar
  11. 11.
    Mehler MF. Epigenetics and the nervous system. Ann Neurol. 2008;64:602–17.CrossRefPubMedGoogle Scholar
  12. 12.
    Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 2009;8:1056–72.CrossRefPubMedGoogle Scholar
  13. 13.
    Dupont C, Armant DR, Brenner CA. Epigenetics: definitions, mechanisms and clinical perspective. Semin Reprod Med. 2009;27(5):351–7.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.CrossRefGoogle Scholar
  15. 15.
    Persico AM, Verdecchia M, Pinzone V, Guidetti V. Migraine genetics: current findings and future lines of research. Neurogenetics. 2015;16(2):77–95.CrossRefPubMedGoogle Scholar
  16. 16.
    Polderman TJC, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM, Posthuma D. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet. 2015;47(7):702–9. doi: 10.1038/ng.3285.CrossRefPubMedGoogle Scholar
  17. 17.
    Lashley KS. Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatr. 1941;46:259–64.CrossRefGoogle Scholar
  18. 18.
    Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117(Pt 1):199–210.CrossRefPubMedGoogle Scholar
  19. 19.
    Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain. 2013;154(Suppl 1):S44–53.CrossRefPubMedGoogle Scholar
  20. 20.
    Park K-Y, Fletcher JR, Raddant AC, Russo AF. Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia. Cephalalgia. 2011;31(5):614–24.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Durham P, Papapetropoulos S. Biomarkers associated with migraine and their potential role in migraine management. Headache. 2013;53(8):1262–77.CrossRefPubMedGoogle Scholar
  22. 22.
    Moschiano F, D’Amico D, Usai S, Grazzi L, Di Stefano M, Ciusani E, Erba N, Bussone G. Homocysteine plasma levels in patients with migraine with aura. Neurol Sci. 2008;29(Suppl 1):S173–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Oterino A, Toriello M, Valle N, Castillo J, Alonso-Arranz A, Bravo Y, Ruiz-Alegria C, Quintela E, Pascual J. The relationship between homocysteine and genes of folate-related enzymes in migraine patients. Headache. 2010;50(1):99–108.CrossRefPubMedGoogle Scholar
  24. 24.
    Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D, Forte A, Girardi N, De Filippis S, Tatarelli R, Martelletti P. Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat. 2010;6:81–91.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Pompili M, Serafini G, Innamorati M, Serra G, Dominici G, Fortes-Lindau J, Pastina M, Telesforo L, Lester D, Girardi P, Tatarelli R, Martelletti P. Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat Outcome Meas. 2010;1:107–18.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Spasić M, Živković M, Lukić S. Prophylactic treatment of migraine by valproate. Med Biol. 2003;10(3):106–10.Google Scholar
  27. 27.
    Passaro D, Rana G, Piscopo M, Viggiano E, De Luca B, Fucci L. Epigenetic chromatin modifications in the cortical spreading depression. Brain Res. 2010;1329:1–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Nelson ED, Monteggia LM. Epigenetics in the mature mammalian brain: effects on behavior and synaptic transmission. Neurobiol Learn Mem. 2011;96(1):53–60.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Park JW, Chu MK, Kim JM, Park SG, Cho SJ. Analysis of trigger factors in episodic migraineurs using a smartphone headache diary applications. PLoS One. 2016;11(2):e0149577.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Vecchia D, Pietrobon D. Migraine: a disorder of brain excitatory-inhibitory balance? Trends Neurosci. 2012;35(8):507–20.CrossRefPubMedGoogle Scholar
  31. 31.
    Tietjen GE. Childhood maltreatment and headache disorders. Curr Pain Headache Rep. 2016;20(4):26.CrossRefPubMedGoogle Scholar
  32. 32.
    Lutz PE, Turecki G. DNA methylation and childhood maltreatment: from animal models to human studies. Neuroscience. 2014;264:142–56.CrossRefPubMedGoogle Scholar
  33. 33.
    Tietjen GE, Buse DC, Fanning KM, Serrano D, Reed ML, Lipton RB. Recalled maltreatment, migraine, and tension-type headache: results of the AMPP study. Neurology. 2015;84(2):132–40.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Fan Y, Herrera-Melendez AL, Pestke K, Feeser M, Aust S, Otte C, Pruessner JC, Böker H, Bajbouj M, Grimm S. Early life stress modulates amygdala-prefrontal functional connectivity: implications for oxytocin effects. Hum Brain Mapp. 2014;35(10):5328–39.CrossRefPubMedGoogle Scholar
  35. 35.
    Maizels M, Aurora S, Heinricher M. Beyond neurovascular: migraine as a dysfunctional neurolimbic pain network. Headache. 2012;52(10):1553–65.CrossRefPubMedGoogle Scholar
  36. 36.
    Bellini B, Arruda M, Cescut A, Saulle C, Persico A, Carotenuto M, Gatta M, Nacinovich R, Piazza FP, Termine C, Tozzi E, Lucchese F, Guidetti V. Headache and comorbidity in children and adolescents. J Headache Pain. 2013;14(1):79.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Minen MT, Begasse De Dhaem O, Kroon Van Diest A, Powers S, Schwedt TJ, Lipton R, Silbersweig D. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 2016;87(7):741–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Qureshi IA, Mehler MF. Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis. 2010;39(1):53–60.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Sun H, Kennedy PJ, Nestler EJ. Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology. 2013;38(1):124–37.CrossRefPubMedGoogle Scholar
  40. 40.
    Murphy TM, O’Donovan A, Mullins N, O’Farrelly C, McCann A, Malone K. Anxiety is associated with higher levels of global DNA methylation and altered expression of epigenetic and interleukin-6 genes. Psychiatr Genet. 2015;25(2):71–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Udali S, Guarini P, Moruzzi S, Choi SW, Friso S. Cardiovascular epigenetics: from DNA methylation to microRNAs. Mol Asp Med. 2013;34(4):883–901.CrossRefGoogle Scholar
  42. 42.
    Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, De Bonis ML, Vacca M, D’Esposito M, D'Urso M, Galletti P, Zappia V. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet. 2003;361(9370):1693–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Baccarelli A, Rienstra M, Benjamin EJ. Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ Cardiovasc Genet. 2010;3(6):567–73.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Fu L-H, Cong B, Zhen Y-F, Li S-J, Ma C-L, Ni Z-Y, Zhang GZ, Zuo M, Yao Y-X. Methylation status of the IL-10 gene promoter in the peripheral blood mononuclear cells of rheumatoid arthritis patients. Yi Chuan. 2007;29(11):1357–61.CrossRefPubMedGoogle Scholar
  45. 45.
    Goadsby P, Lipton R, Ferrari M. Migraine—current understanding and treatment. N Engl J Med. 2002;346(4):257–70.CrossRefPubMedGoogle Scholar
  46. 46.
    Powers SW, Kashikar-Zuck SM, Allen JR, LeCates SL, Slater SK, Zafar M, Kabbouche MA, O’Brien HL, Shenk CE, Rausch JR, Hershey AD. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310(24):2622–30.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Andrew D. Hershey
    • 1
  • Vincenzo Guidetti
    • 2
  • Noemi Faedda
    • 2
  1. 1.Division of Neurology, Cincinnati Children’s Hospital Medical Center and Department of PediatricsCollege of Medicine, University of CincinnatiCincinnatiUSA
  2. 2.Department of Pediatric and Child and Adolescent NeuropsychiatrySapienza University of RomeRomeItaly

Personalised recommendations